S100B suppression alters polarization of infiltrating myeloid-derived cells in gliomas and inhibits tumor growth
Hang Gao(Zhejiang Chinese Medical University), Behnam Badie(City Of Hope National Medical Center), Hui Ren(Tongji University), Yanyan Song(Second Affiliated Hospital of Jilin University), Huili Liu(Chinese Academy of Sciences), Leying Zhang(City Of Hope National Medical Center), Yanping Su(Fujian Medical University), Hui Zhou(Zhejiang A & F University), Shunan Liu(Jilin University), Yihang Yang(Shandong University), Ian Y. Zhang(Beijing Tongren Hospital)
Cited by 47
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
|Frontiers in Immunology|2017|216